AEGiS-15IAC: Osteonecrosis and HIV: report of a case.

15th International AIDS Conference


Bangkok, Thailand - July 11-16, 2004

DonateNow
Print this article

Osteonecrosis and HIV: report of a case.

Int Conf AIDS 2004 Jul 11-16; 15:(abstract no. A10165)

Ostuni Rocca MC, Vilda MC, Agugliaro RH, Iussig M, Dellabianca G, Lemos S
Hospital Zubizarreta, Bs. As., Argentina

BACKGROUND: It seems that osteopathy is a raising entity in HIV population since 1990. In non-HIV patients, osteonecrosis is related to collagen diseases, smoking, gout, and cancer. These entities could take part in HIV population too, but there are other risks factors postulated: protease-inhibitor thrapy, treatment with steroids or testosterone, vasculitis and immune system improvement. Methods-

RESULTS: We describe a case of osteonecrosis in a HIV patient. He is 34 years of age with a twelve-year history of HIV. The first signs of the illness were of an increased intracranial pressure with a focal motor deficits, due to a CNS toxoplasmosis. He was well after the treatment, but needed high doses of steroids because of a severe skin rash. Since that moment he is under an antirretroviral scheme which includes protease inhibitors. On April 2003, he presented with a seven days high intensity back pain with no response to common anti-inflammatory agents. The clinical examination and the routine laboratory were normal. RX was suggestive of osteonecrosis, that was confirmed by RMI and technetium scan.

CONCLUSION: Osteonecrosis should be included into the differential diagnosis of an AIDS+ patient with osteoarticular pain, specially if there is no response to common anti-inflammatory agents. An accurate diagnosis could allow a correct treatment and a better outcome.

Keywords: AEGIS, HIV, Acquired Immunodeficiency Syndrome, HIV Seropositivity, Osteonecrosis, HIV Infections, Risk Factors, HIV Protease Inhibitors, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Toxoplasmosis, Cerebral, Drug Therapy, Combination, Humans, organization & administration, methods, therapy, drug therapy

040711
A10165

Copyright © 2004 - International AIDS Society (IAS). Reproduction of this abstract (other than one copy for personal reference) must be cleared through the IAS.